Hokkaido University Collection of Scholarly and Academic Papers >
Graduate School of Medicine / Faculty of Medicine >
Peer-reviewed Journal Articles, etc >
Lysophosphatidic acid activates Arf6 to promote the mesenchymal malignancy of renal cancer
This item is licensed under:Creative Commons Attribution 4.0 International
Title: | Lysophosphatidic acid activates Arf6 to promote the mesenchymal malignancy of renal cancer |
Authors: | Hashimoto, Shigeru Browse this author →KAKEN DB | Mikami, Shuji Browse this author →KAKEN DB | Sugino, Hirokazu Browse this author | Yoshikawa, Ayumu Browse this author | Hashimoto, Ari Browse this author →KAKEN DB | Onodera, Yasuhito Browse this author →KAKEN DB | Furukawa, Shotaro Browse this author | Handa, Haruka Browse this author | Oikawa, Tsukasa Browse this author →KAKEN DB | Okada, Yasunori Browse this author →KAKEN DB | Oya, Mototsugu Browse this author →KAKEN DB | Sabe, Hisataka Browse this author →KAKEN DB |
Issue Date: | 8-Feb-2016 |
Publisher: | Nature Publishing Group |
Journal Title: | Nature communications |
Volume: | 7 |
Start Page: | 10656 |
Publisher DOI: | 10.1038/ncomms10656 |
Abstract: | Acquisition of mesenchymal properties by cancer cells is critical for their malignant behaviour, but regulators of the mesenchymal molecular machinery and how it is activated remain elusive. Here we show that clear cell renal cell carcinomas (ccRCCs) frequently utilize the Arf6-based mesenchymal pathway to promote invasion and metastasis, similar to breast cancers. In breast cancer cells, ligand-activated receptor tyrosine kinases employ GEP100 to activate Arf6, which then recruits AMAP1; and AMAP1 then binds to the mesenchymal-specific protein EPB41L5, which promotes epithelial-mesenchymal transition and focal adhesion dynamics. In renal cancer cells, lysophosphatidic acid (LPA) activates Arf6 via its G-protein-coupled receptors, in which GTP-G alpha 12 binds to EFA6. The Arf6-based pathway may also contribute to drug resistance. Our results identify a specific mesenchymal molecular machinery of primary ccRCCs, which is triggered by a product of autotaxin and it is associated with poor outcome of patients. |
Rights: | http://creativecommons.org/licenses/by/4.0/ |
Type: | article |
URI: | http://hdl.handle.net/2115/61333 |
Appears in Collections: | 医学院・医学研究院 (Graduate School of Medicine / Faculty of Medicine) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)
|
Submitter: 佐邊 壽孝
|